IN190849B - - Google Patents

Info

Publication number
IN190849B
IN190849B IN653DE2000A IN190849B IN 190849 B IN190849 B IN 190849B IN 653DE2000 A IN653DE2000 A IN 653DE2000A IN 190849 B IN190849 B IN 190849B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Om Dutt Tyagi
Gyan Chand Yadav
Vijay Kumar Handa
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN653DE2000 priority Critical patent/IN190849B/en
Priority to US09/906,256 priority patent/US6833452B2/en
Priority to CA002416695A priority patent/CA2416695A1/en
Priority to JP2002512191A priority patent/JP2004504325A/ja
Priority to CN01814420A priority patent/CN1447812A/zh
Priority to BR0112598-2A priority patent/BR0112598A/pt
Priority to EP01949815A priority patent/EP1303523A1/en
Priority to PCT/IB2001/001259 priority patent/WO2002006289A1/en
Priority to AU2001270928A priority patent/AU2001270928A1/en
Priority to ZA200300472A priority patent/ZA200300472B/en
Publication of IN190849B publication Critical patent/IN190849B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN653DE2000 2000-07-17 2000-07-17 IN190849B (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IN653DE2000 IN190849B (sv) 2000-07-17 2000-07-17
US09/906,256 US6833452B2 (en) 2000-07-17 2001-07-16 Process for the preparation of highly pure crystalline (R,S)—cefuroxime axetil
CA002416695A CA2416695A1 (en) 2000-07-17 2001-07-16 Process for the preparation of highly pure crystalline (r,s) - cefuroxime axetil
JP2002512191A JP2004504325A (ja) 2000-07-17 2001-07-16 高度に純粋な結晶性（ｒ，ｓ）−セフロキシムアキセチルの製法
CN01814420A CN1447812A (zh) 2000-07-17 2001-07-16 制造高纯度结晶(r,s)一头孢呋辛酯的方法
BR0112598-2A BR0112598A (pt) 2000-07-17 2001-07-16 Processo para a preparação de (r,s)-axetil cefuroxima cristalina de alta pureza
EP01949815A EP1303523A1 (en) 2000-07-17 2001-07-16 Process for the preparation of the highly pure crystalline (r, s) - cefuroxime axetil
PCT/IB2001/001259 WO2002006289A1 (en) 2000-07-17 2001-07-16 Process for the preparation of highly pure crystalline (r,s) - cefuroxime axetil
AU2001270928A AU2001270928A1 (en) 2000-07-17 2001-07-16 Process for the preparation of highly pure crystalline (R,S) - cefuroxime axetil
ZA200300472A ZA200300472B (en) 2000-07-17 2003-01-17 Process for the preparation of highly pure crystalline (R,S)-cefuroxime axetil.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN653DE2000 IN190849B (sv) 2000-07-17 2000-07-17

Publications (1)

Publication Number Publication Date
IN190849B true IN190849B (sv) 2003-08-23

Family

ID=11097069

Family Applications (1)

Application Number Title Priority Date Filing Date
IN653DE2000 IN190849B (sv) 2000-07-17 2000-07-17

Country Status (10)

Country Link
US (1) US6833452B2 (sv)
EP (1) EP1303523A1 (sv)
JP (1) JP2004504325A (sv)
CN (1) CN1447812A (sv)
AU (1) AU2001270928A1 (sv)
BR (1) BR0112598A (sv)
CA (1) CA2416695A1 (sv)
IN (1) IN190849B (sv)
WO (1) WO2002006289A1 (sv)
ZA (1) ZA200300472B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT411996B (de) * 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
DE60136229D1 (de) * 2001-07-25 2008-11-27 Lupin Ltd Verbessertes verfahren zur herstellung von cefuroxime axetil
US6537985B1 (en) * 2001-11-30 2003-03-25 Phoenix Scientific, Inc. Antibiotic formulation and a method of making this formulation
US20030135041A1 (en) 2002-01-04 2003-07-17 Orchid Chemicals & Pharmaceuticals Limited, India Synthesis of ceftiofur intermediate
CN100448879C (zh) 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
ITMI20050871A1 (it) * 2005-05-13 2006-11-14 Acs Dobfar Spa Solvato cristallino di cefuroxima acido
DE102006019619A1 (de) * 2006-04-25 2007-10-31 Grünenthal GmbH Kristalline Modifikation von Cefuroximaxetil
CN103435632B (zh) * 2013-09-12 2016-03-02 广东立国制药有限公司 一种头孢呋辛酯的制备方法
CN105131016A (zh) * 2015-08-04 2015-12-09 江苏正大清江制药有限公司 一种头孢呋辛酯的制备方法
CN106554361B (zh) * 2016-09-30 2018-10-09 华北制药河北华民药业有限责任公司 一种头孢呋辛酯口服制剂的制备方法
CN108586493A (zh) * 2017-12-18 2018-09-28 蚌埠丰原医药科技发展有限公司 一种结晶型头孢呋辛酯的制备方法
CN109705144A (zh) * 2019-03-05 2019-05-03 安徽丰原利康制药有限公司 一种头孢呋辛酯高得率的生产方法
CN109705143A (zh) * 2019-03-05 2019-05-03 安徽丰原利康制药有限公司 一种头孢呋辛酯提纯的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
YU44680B (en) 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320521D0 (en) 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
JPH02104590A (ja) * 1987-06-15 1990-04-17 Toyohiko Kikuchi 抗生物質の製造方法
US5063224A (en) 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
JP3121903B2 (ja) * 1992-02-07 2001-01-09 塩野義製薬株式会社 デアセチルセファロスポラン酸のカルバモイル化方法
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
CN1111537C (zh) * 1997-05-15 2003-06-18 第一制糖株式会社 高纯晶形头孢呋辛1－乙酰氧乙酯的制备方法
EP0937727B1 (de) * 1998-02-20 2002-01-30 Fako Ilaclari A.S. Verfahren zur Herstellung vom löslichen kristallinen Cefuroxim axetil
AT411996B (de) * 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
DE60136229D1 (de) * 2001-07-25 2008-11-27 Lupin Ltd Verbessertes verfahren zur herstellung von cefuroxime axetil

Also Published As

Publication number Publication date
AU2001270928A1 (en) 2002-01-30
CN1447812A (zh) 2003-10-08
EP1303523A1 (en) 2003-04-23
US20020016456A1 (en) 2002-02-07
JP2004504325A (ja) 2004-02-12
CA2416695A1 (en) 2002-01-24
ZA200300472B (en) 2003-10-16
WO2002006289A1 (en) 2002-01-24
US6833452B2 (en) 2004-12-21
BR0112598A (pt) 2003-08-12

Similar Documents

Publication Publication Date Title
JP2001199105A5 (sv)
AR028236A3 (sv)
AU2000236813A8 (sv)
JP2003519751A5 (sv)
JP2002540677A5 (sv)
IN190849B (sv)
JP2003517609A5 (sv)
JP2002539170A5 (sv)
JP2001350162A5 (sv)
JP2002193212A5 (sv)
JP2001232790A5 (sv)
HU0004808D0 (sv)
CN3147656S (sv)
CN3142146S (sv)
CN3152757S (sv)
CN3152744S (sv)
CN3151695S (sv)
CN3141398S (sv)
CN3149762S (sv)
CN3149382S (sv)
CN3149303S (sv)
CN3149068S (sv)
CN3148468S (sv)
CN3141406S (sv)
CN3147541S (sv)